Phospholipid hydroxyalkenals: Biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 2, 2003, Pages 275-282

  Hoff, Henry F ^a   O'Neil, June ^a   Wu, Zhiping ^a   Hoppe, George ^a   Salomon, Robert L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Atherosclerotic lesions; Biochemical adducts; Macrophages intracellular degradation; Oxidized phospholipids; Rab5

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DERIVATIVE; ALKENE DERIVATIVE; ARACHIDONIC ACID; BOVINE SERUM ALBUMIN; CATHEPSIN B; CYSTEINE; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; LYSOSOME ENZYME; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEINASE; PYRROLE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LYSOSOME; MACROMOLECULE; MASS SPECTROMETRY; MEMBRANE FUSION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ACETYLCYSTEINE; ALDEHYDES; ANIMALS; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT; CATHEPSIN B; CHOLESTEROL ESTERS; CHROMATOGRAPHY, LIQUID; HUMANS; INTRACELLULAR MEMBRANES; LIPOPROTEINS, LDL; LYSINE; LYSOSOMES; MACROPHAGES, PERITONEAL; MICE; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PYRROLES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0037329336     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000051407.42536.73     Document Type: Article

References (39)

1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792.
2. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81-128.
3. Juergens G, Hoff HF, Chisolm GM, Esterbauer H. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiological implications. Chem Phys Lipids. 1987;45:315-336.
4. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
5. Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. J Biol Chem. 1999;274:23737-23793.
6. Friguet B, Szweda L, Stadtman E. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys. 1994;311:168-173.
7. Crabb JW, O'Neil J, Miyagi M, West K, Hoff HF. 4-Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Prot Sci. 2002;11:831-840.
8. Hoppe GB, O'Neil J, Hoff HF. Inactivation of lysosomal proteases by oxidized LDL is partially responsible for its poor degradation by mouse peritoneal macrophages. J Clin Invest. 1994;94:1506-1512.
9. O'Neil J, Hoppe G, Sayre L, Hoff HF. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of reactive sites exposed at low pH to thiols on the enzyme. Free Radic Biol Med. 1997;23:215-225.
10. Uchida K, Toyokuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H, Stadtman ER. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry. 1994;33:12487-12494.
11. Witz G. Biological interactions of α,β - unsaturated aldehydes. Free Radic Biol Med. 1989;7:333-349.
12. Salomon RG, Kaur K, Deng Y, Sha W, Podrez EA, Hoff HF, Sayre LM. HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic lesions. Chem Res Toxicol. 2000;13:557-564.
13. Hoff HF, O'Neil JA. Modification of LDL with 4-hydroxynonenal and malondialdehyde as a model for soluble oxidized LDL. J Lipid Res. 1993;34:1209-1217.
14. Hoff HF, O'Neil J, Chisolm GM, Cole TB, Quehenberger O, Esterbauer H, Jürgens G. Modification of LDL with 4-hydroxynonenal induces uptake of LDL by macrophages. Arteriosclerosis. 1989;9:538-549.
15. Mlakar A, Spiteller G. Previously unknown aldehydic lipid peroxidation compounds of arachidonic acid. Chem Phys Lipids. 1997;79:47-53.
16. Kaur K, Salomon RG, O'Neil J, Hoff HF. Carboxyalkyl pyrroles in human plasma and oxidized low density lipoproteins. Chem Res Toxicol. 1998;10:1387-1396.
17. Deng Y, Salomon RG. Total synthesis of γ-hydroxy-α,β-unsaturated aldehydic esters of cholesterol and 2-lysophosphatidylcholine. J Org Chem. 1999;63:1347-1360.
18. Uchida K, Stadtman ER. Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal. Proc Natl Acad Sci USA. 1992;89:5611-5615.
19. Hoppe G, Marmorstein A, Pennock E, Hoff HF. Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE. Invest Ophthalmol Vis Sci. 2001;42:2714-2720.
20. Alvarez-Dominguez C, Stahl PD. Interferon-gamma selectively induces Rab5a synthesis and processing in mononuclear cells. J Biol Chem. 1998;18:33901-33904.
21. Hatch FT, Lees RS. Practical method for plasma lipoprotein analysis. Adv Lipid Res. 1968;6:2-63.
22. Bligh EG, Dyer DW. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
23. Haberland ME, Fogelman AM. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophages. Proc Natl Acad Sci U S A. 1985;82:2693-2697.
24. McFarlane AS. Efficient trace-labeling of proteins with iodine. Nature. 1958;182:53-57.
25. Bajkowski AS, Frankfater A. Specific spectrophotometric assays for cathepsin BI. Anal Biochem. 1975;68:119-127.
26. Uchida K, Szweda LI, Chae HZ, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A. 1993;90:8742-8746.
27. Watson AD, Leitinger N, Navab M, Faull F, Hörkkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597-13607.
28. Young RW, Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol. 1969;42:392-403.
29. Xu G, Liu Y, Sayre LM. Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross-linking of proteins by (E)-4-hydroxy-2-nonenal (HNE). J Org Chem. 1999;64:5732-5745.
30. Podrez EA, Batyreva E, Shen Z, Zang Z, Deng Y, Sun M, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL. A novel family of atherogenic oxidized phospholipids promotes foam cell formation via the scavenger receptor CD36 and is present in atherosclerotic lesions. J Biol Chem. 2002;277:38517-38523.
31. Ahmed Z, Ravandi A, Maguire GF, Emili A, Draganov D, LaDu BN, Kuksis A, Connelly PH. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. J Biol Chem. 2001;276:24473-24481.
32. Subbanagounder G, Deng Y, Borromeo C, Dolley AK, Berliner JA, Salomon RG. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vasc Pharmacol. 2002;8:1-10.
33. 2 in vascular disease. Circ Res. 2001;89:298-304.
34. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation-specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 1990;10:336-349.
35. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficientt mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994;14:605-616.
36. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein R, Hajjar DP, Cohen P, Frazier WA, Hoff HF, Hazen SL. The macrophage scavenger receptor CD36 is the major pathway for LDL recognition following modification by monocyte-generated reactive nitrogen species. J Clin Invest. 2000;105:1095-1108.
37. Podrez EA, Batyreva E, Shen Z, Zhang Z, Deng Y, Sun M, Hoff HF, Salomon RG, Hazen SL. Identification of a novel class of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem. 2002;277:38503-38516.
38. Bird DA, Gillote KL, Horrko S, Friedman P, Dennis EA, Witztum JL, Steinberg D. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci USA. 1999;96:6347-6352.
39. Boullier A, Gillotte KL, Horkko S, Green SR, Friedman P, Dennis EA, Witztum JL, Steinberg D, Quehenberger O. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem. 2000;275:9163-9169.